Jennifer Pafiti
Pomerantz LLP
- Address of record
- 1100 Glendon Avenue, 15th Floor, Los Angeles, CA 90024, (310) 405-7190
- jpafiti@pomlaw.com
- Phone
- (310) 405-7190
- Fax
- Fax 917-463-1044
Contact details as filed with the court in the cases below.
Case history
Publicly tracked matters where this attorney is listed as counsel.
Luna Innovations Incorporated Securities Litigation Settlement
Investors filed a securities class action alleging violations of Sections 10(b) and 20(a) of the Securities Exchange Act related to Luna Innovations Inc. securities. Luna Innovations Inc. and officers Scott A. Graeff, Eugene J. Nestro, and George Gomez-Quintero have agreed to settle the claims for $7,300,000 in cash. The defendants admit no wrongdoing.
- Settlement fund
- $7.3M
- Claim deadline
- January 16, 2026
- Represents
- Zachari Pirbudagov
Masimo Securities Settlement
Masimo Corporation allegedly made misleading statements or omissions regarding its publicly traded common stock. Shareholders claim they were damaged by purchasing or acquiring the stock during the class period.
- Claim deadline
- April 28, 2026
- Represents
- Haiyu Wang
Proterra Inc. Securities Litigation Settlement
Proterra Inc. and its defendants are settling securities litigation brought by shareholders who claim they were harmed by alleged misconduct related to Proterra's business combination with ArcLight Clean Transition Corp. and subsequent stock sales. The defendants are paying $29 million to resolve all claims without admitting wrongdoing.
- Settlement fund
- $29M
- Claim deadline
- August 29, 2025
- Represents
- Tanya Tirado, Luong Du
ImmunityBio Inc. Securities Litigation Settlement
Lead Plaintiff alleges that ImmunityBio, Inc. and its executives made false or misleading statements regarding the company's securities during the class period. The defendants have agreed to settle the litigation for $10,500,000 in cash without admitting wrongdoing.
- Settlement fund
- $10.5M
- Claim deadline
- July 7, 2025
- Represents
- Zachary Salzman, Dipak T Patel
Tattooed Chef Securities Settlement
Tattooed Chef, Inc. faced a securities lawsuit alleging that purchasers of the company's common stock were damaged. The defendant has agreed to settle all claims in the action for $4,750,000 in cash without admitting wrongdoing.
- Settlement fund
- $4.8M
- Claim deadline
- August 4, 2026
- Represents
- Ben Ganje, Mohamed Saad, Nassib Awad
Silvergate Capital Corporation Securities Litigation Settlement
Silvergate Capital Corporation allegedly violated federal securities laws by making false and misleading statements about Silvergate Bank's vetting, due diligence, and monitoring of customers. The company has agreed to settle for $37.5 million without admitting wrongdoing.
- Settlement fund
- $37.5M
- Claim deadline
- October 21, 2025
- Represents
- Jacob Guz
Olaplex Securities Settlement
Olaplex is settling a securities class action lawsuit alleging that the company made misrepresentations in its initial public offering documents. The defendant does not admit wrongdoing.
- Claim deadline
- November 24, 2025
- Represents
- Leslie Lilien
Wells Fargo Securities Action Settlement
Wells Fargo allegedly made false and misleading statements about its diversity hiring initiative, the Diverse Search Requirement. The company failed to disclose that it was conducting widespread "fake" or sham interviews of diverse candidates under this policy. When The New York Times revealed this conduct on June 9, 2022, Wells Fargo shareholders suffered losses. Wells Fargo denies all allegations and admits no wrongdoing.
- Settlement fund
- $85M
- Claim deadline
- April 14, 2026
- Represents
- Khosrow Ardalan, Employees Retirement System of Rhode Island
View Inc. Securities Litigation Settlement
Investors purchased View, Inc. (formerly CF Finance Acquisition Corp. II) securities during a specified period and are now participating in a settlement. The defendants have agreed to a settlement of $11 million to resolve securities claims, though the page does not specify what defendants allegedly did wrong or whether they admit liability.
- Settlement fund
- $11M
- Claim deadline
- December 5, 2025
- Represents
- Majdi Mojahed
FibroGen, Inc. Securities Litigation Settlement
FibroGen and its executives allegedly misrepresented the safety profile and Phase III trial results of its anti-anemia drug Roxadustat in filings with the FDA. Investors claim the company's stock price was artificially inflated by these false statements and declined when the truth was revealed. The defendants deny all allegations of wrongdoing.
- Settlement fund
- $28.5M
- Claim deadline
- Represents
- Cesare Grazioli
Tricida Securities Settlement
Tricida, Inc. and defendant Gerrit Klaerner are alleged to have violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. The defendant denies all claims and wrongdoing. The settlement resolves these allegations without admission of liability.
- Settlement fund
- $14.3M
- Claim deadline
- October 1, 2025
- Represents
- Michael Pardi, Donna Situ
“Recovery” and “exposure” refer to total disclosed settlement funds in associated cases, not money personally won or lost by an attorney. Settlements generally resolve disputed allegations without a finding that either side won. Data comes from public court dockets and may be incomplete.